2/In @doudna_lab’s vision - the future of #CRISPR #GeneEditing will intersect with other #technologies such as #MachineLearning, cell #Imaging & #Sequencing while #FDA approval for the first $CRSP CRISPR-based medicine will help advance others to later stages of #clinicaltrials. https://t.co/lRcaNmatQv
A new @CellCellPress Special Review issue on #Therapeutics: #Cancer, #autoimmune #disease, #vaccines, #RareDisease #MachineLearning and #medicine, #CRISPR #AAV, #pharma #neurodegeneration - its all @ http://bit.ly/2V9mLV1 https://t.co/TXz3prO4yu